Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lai

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Clinical and Experimental Medicine|August 12, 2024
Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian populationBo-Fang Chen, Yi-Fang Tsai, Ta-Chung Chao, et al.
Annals of Surgery|April 11, 2025
Randomized Controlled Trial - Perioperative Telemonitoring of Patient Generated Health Data in Gastrointestinal Oncologic (GI) Surgery: Assessing OutcomesKelly M Mahuron, Patricia Esslin, Virginia Sun, et al.
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
Frontiers in Oncology|September 1, 2023
Prevalence of <i>PIK3CA</i> mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysisTa-Chung Chao, Yi-Fang Tsai, Chun-Yu Liu, et al.
Breast Cancer (Tokyo, Japan)|December 9, 2023
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in TaiwanBo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, et al.
The Oncologist|July 12, 2019
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal CancerMing-Huang Chen, Shih-Ching Chang, Pei-Ching Lin, et al.
ACS Applied Materials & Interfaces|March 11, 2017
Crystalline Engineering Toward Large-Scale High-Efficiency Printable Cu(In,Ga)Se<sub>2</sub> Thin Film Solar Cells on Flexible Substrate by Femtosecond Laser Annealing ProcessShih-Chen Chen, Nian-Zu She, Kaung-Hsiung Wu, et al.
Annals of Surgical Oncology|February 28, 2022
Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast CancersChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Translational Oncology|September 15, 2023
Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancersLing-Ming Tseng, Chi-Cheng Huang, Yi-Fang Tsai, et al.
Breast Cancer Research : BCR|December 30, 2025
Circulating T-cell receptor repertoire and clinicopathological correlations in breast cancer patients: immune repertoire analysis from the VGH-TAYLOR studyLing-Ming Tseng, Chi-Cheng Huang, Ji-Lin Chen, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Clinical and Experimental Medicine|August 12, 2024
Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian populationBo-Fang Chen, Yi-Fang Tsai, Ta-Chung Chao, et al.
Annals of Surgery|April 11, 2025
Randomized Controlled Trial - Perioperative Telemonitoring of Patient Generated Health Data in Gastrointestinal Oncologic (GI) Surgery: Assessing OutcomesKelly M Mahuron, Patricia Esslin, Virginia Sun, et al.
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
Frontiers in Oncology|September 1, 2023
Prevalence of <i>PIK3CA</i> mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysisTa-Chung Chao, Yi-Fang Tsai, Chun-Yu Liu, et al.
Breast Cancer (Tokyo, Japan)|December 9, 2023
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in TaiwanBo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, et al.
The Oncologist|July 12, 2019
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal CancerMing-Huang Chen, Shih-Ching Chang, Pei-Ching Lin, et al.
ACS Applied Materials & Interfaces|March 11, 2017
Crystalline Engineering Toward Large-Scale High-Efficiency Printable Cu(In,Ga)Se<sub>2</sub> Thin Film Solar Cells on Flexible Substrate by Femtosecond Laser Annealing ProcessShih-Chen Chen, Nian-Zu She, Kaung-Hsiung Wu, et al.
Annals of Surgical Oncology|February 28, 2022
Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast CancersChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Translational Oncology|September 15, 2023
Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancersLing-Ming Tseng, Chi-Cheng Huang, Yi-Fang Tsai, et al.
Breast Cancer Research : BCR|December 30, 2025
Circulating T-cell receptor repertoire and clinicopathological correlations in breast cancer patients: immune repertoire analysis from the VGH-TAYLOR studyLing-Ming Tseng, Chi-Cheng Huang, Ji-Lin Chen, et al.
Pageof 16